INR 127.95
(6.14%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 705.74 Million INR | 2.35% |
2022 | 689.52 Million INR | 13.39% |
2021 | 608.09 Million INR | 3.96% |
2020 | 584.94 Million INR | 7.12% |
2019 | 546.08 Million INR | 1.82% |
2018 | 536.34 Million INR | 8.19% |
2017 | 495.75 Million INR | 2.34% |
2016 | 484.4 Million INR | 7.38% |
2015 | 451.13 Million INR | -27.59% |
2014 | 623 Million INR | -6.09% |
2013 | 663.43 Million INR | 21.29% |
2012 | 546.96 Million INR | 15.81% |
2011 | 472.3 Million INR | 2.09% |
2010 | 462.64 Million INR | 8.6% |
2009 | 425.99 Million INR | -21.98% |
2008 | 546.02 Million INR | 23.79% |
2007 | 441.08 Million INR | 20.34% |
2006 | 366.52 Million INR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 645.53 Million INR | 0.0% |
2023 Q2 | 596.36 Million INR | 0.0% |
2023 Q4 | 705.74 Million INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 705.74 Million INR | 2.35% |
2023 Q3 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 689.52 Million INR | 0.0% |
2022 Q2 | 545.41 Million INR | 0.0% |
2022 FY | 689.52 Million INR | 13.39% |
2022 Q1 | - INR | -100.0% |
2021 FY | 608.09 Million INR | 3.96% |
2021 Q4 | 608.09 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 580.04 Million INR | 0.0% |
2020 Q4 | 584.94 Million INR | 0.0% |
2020 FY | 584.94 Million INR | 7.12% |
2020 Q2 | 561.68 Million INR | 0.0% |
2019 Q4 | 546.08 Million INR | 0.0% |
2019 FY | 546.08 Million INR | 1.82% |
2019 Q2 | 514.66 Million INR | 0.0% |
2018 Q4 | 536.34 Million INR | 0.0% |
2018 FY | 536.34 Million INR | 8.19% |
2017 FY | 495.75 Million INR | 2.34% |
2017 Q4 | 495.75 Million INR | 0.0% |
2017 Q2 | 450.87 Million INR | 0.0% |
2016 FY | 484.4 Million INR | 7.38% |
2016 Q4 | 643.39 Million INR | 0.0% |
2016 Q2 | 589.95 Million INR | 0.0% |
2015 FY | 451.13 Million INR | -27.59% |
2015 Q2 | 575.96 Million INR | 0.0% |
2015 Q4 | 451.13 Million INR | 0.0% |
2014 Q4 | 623 Million INR | 0.0% |
2014 FY | 623 Million INR | -6.09% |
2013 FY | 663.43 Million INR | 21.29% |
2012 FY | 546.96 Million INR | 15.81% |
2012 Q4 | 546.96 Million INR | 0.0% |
2012 Q2 | 783.86 Million INR | 0.0% |
2011 FY | 472.3 Million INR | 2.09% |
2010 FY | 462.64 Million INR | 8.6% |
2009 FY | 425.99 Million INR | -21.98% |
2008 FY | 546.02 Million INR | 23.79% |
2007 FY | 441.08 Million INR | 20.34% |
2006 FY | 366.52 Million INR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Alembic Pharmaceuticals Limited | 16.43 Billion INR | 95.706% |
Aurobindo Pharma Limited | 98.08 Billion INR | 99.28% |
Glenmark Life Sciences Limited | 6.66 Billion INR | 89.413% |
Granules India Limited | 13 Billion INR | 94.573% |
Indoco Remedies Limited | 3.53 Billion INR | 80.011% |
Achyut Healthcare Limited | 568 Thousand INR | -124150.528% |
Ajanta Pharma Limited | 8.28 Billion INR | 91.48% |
Alkem Laboratories Limited | 26.61 Billion INR | 97.348% |
Alpa Laboratories Limited | 136.65 Million INR | -416.449% |
Brooks Laboratories Limited | 96.1 Million INR | -634.323% |
AstraZeneca Pharma India Limited | 2.27 Billion INR | 69.03% |
Bajaj HealthCare Limited | 1.44 Billion INR | 51.003% |
Bliss GVS Pharma Limited | 1.18 Billion INR | 40.417% |
Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 98.89% |
Eris Lifesciences Limited | 1.89 Billion INR | 62.665% |
FDC Limited | 3.88 Billion INR | 81.852% |
Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 97.192% |
Gufic Biosciences Limited | 2 Billion INR | 64.798% |
Ind-Swift Laboratories Limited | 104.57 Million INR | -574.855% |
Ipca Laboratories Limited | 24.71 Billion INR | 97.144% |
Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -370.589% |
Krebs Biochemicals & Industries Limited | 97.96 Million INR | -620.411% |
Lasa Supergenerics Limited | 190.43 Million INR | -270.597% |
Laurus Labs Limited | 18.45 Billion INR | 96.176% |
Lupin Limited | 49.53 Billion INR | 98.575% |
Mankind Pharma Limited | 15.53 Billion INR | 95.457% |
Medicamen Biotech Limited | 593.75 Million INR | -18.862% |
Medico Remedies Limited | 163.37 Million INR | -331.985% |
Megasoft Limited | - INR | -Infinity% |
NATCO Pharma Limited | 7 Billion INR | 89.925% |
Piramal Pharma Limited | 21.75 Billion INR | 96.757% |
RPG Life Sciences Limited | 1.01 Billion INR | 30.124% |
Sigachi Industries Limited | 707.2 Million INR | 0.207% |
Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.285% |
Suven Pharmaceuticals Limited | 2.31 Billion INR | 69.474% |
Syncom Formulations (India) Limited | 210.81 Million INR | -234.769% |
Unichem Laboratories Limited | 7.04 Billion INR | 89.985% |
Wanbury Limited | 360.23 Million INR | -95.913% |
Windlas Biotech Limited | 621.89 Million INR | -13.484% |
ZIM Laboratories Limited | 812.62 Million INR | 13.153% |
Zydus Lifesciences Limited | 34.41 Billion INR | 97.95% |
Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
Divi's Laboratories Limited | 31.84 Billion INR | 97.783% |
Hester Biosciences Limited | 755.81 Million INR | 6.624% |
Procter & Gamble Health Limited | 1.09 Billion INR | 35.318% |
Amrutanjan Health Care Limited | 289.04 Million INR | -144.162% |
Bal Pharma Limited | 878.11 Million INR | 19.63% |
Strides Pharma Science Limited | 11.26 Billion INR | 93.734% |
Venus Remedies Limited | 1.21 Billion INR | 42.005% |
Aarti Pharmalabs Limited | 6.42 Billion INR | 89.022% |
Nectar Lifesciences Limited | 7.09 Billion INR | 90.048% |
Shilpa Medicare Limited | 3.44 Billion INR | 79.539% |
Aarti Drugs Limited | 4.85 Billion INR | 85.475% |
IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 83.388% |
Suven Life Sciences Limited | 7.08 Million INR | -9861.087% |
Ind-Swift Limited | 640.91 Million INR | -10.115% |
Valiant Laboratories Limited | 100.15 Million INR | -604.658% |
J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 85.956% |
Solara Active Pharma Sciences Limited | 3.59 Billion INR | 80.38% |
Hikal Limited | 3.03 Billion INR | 76.763% |
Torrent Pharmaceuticals Limited | 22.79 Billion INR | 96.903% |
Sequent Scientific Limited | 3.46 Billion INR | 79.616% |
Novartis India Limited | 448.6 Million INR | -57.321% |
Wockhardt Limited | 6.4 Billion INR | 88.973% |
Jubilant Pharmova Limited | 12.89 Billion INR | 94.527% |
Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -2667.945% |
Neuland Laboratories Limited | 3.5 Billion INR | 79.86% |
Morepen Laboratories Limited | 2.48 Billion INR | 71.611% |
Kilitch Drugs (India) Limited | 39.88 Million INR | -1669.666% |
Mangalam Drugs & Organics Limited | 1.23 Billion INR | 42.919% |